🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies the effect of belinostat and SGI-110 (guadecita...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2020-09-08
Trial ID
NCT04340843
The purpose of the study is to determine if cladribine tablets are a safe a...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT00213135
Treatments Being Tested
The vast majority of patients with ALL will die of the disease, and no stan...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2016-01-01
Trial ID
NCT03318419
Treatments Being Tested
The vast majority of patients with AML will die of the disease, and no stan...
Status
Unknown
Location
Liang Wang
Start Date
2016-01-01
Trial ID
NCT03181815
Treatments Being Tested
To study the impact of cladribine on peripheral and intrathecal B-cell, pla...
Status
Completed
Location
Barts Health NHS Trust
Start Date
2019-07-01
Trial ID
NCT06415864
This study is designed to examine blood levels of ASTX727, a fixed-dose com...
Status
Completed
Location
Roswell Park
Start Date
2018-11-08
Trial ID
NCT03813186
Treatments Being Tested
CLAG-M is an active, well tolerated regimen in acute myelogenous leukemia. ...
Status
Unknown
Location
Westchester Medical Center/New York Medical College
Start Date
2012-01
Trial ID
NCT01513603
The study will include newly-diagnosed AML patients, not suffering acute pr...
Status
Unknown
Location
Weill Cornell Medicine
Start Date
2017-07-03
Trial ID
NCT03257241
Treatments Being Tested
MS is a chronic inflammatory and degenerative disease of the central nervou...
Status
Active Not Recruiting
Location
Queens University Belfast (Belfast Health and Social Care Trust)
Start Date
2021-06-25
Trial ID
NCT04695080
Treatments Being Tested
To evaluate the safety, pharmacokinetics (PK), and efficacy of ASTX660 when...
Status
Terminated
Location
University of California San Francisco
Start Date
2020-06-12
Trial ID
NCT04155580